News

Petroleum demand hits 18-year low

Despite the demand for petroleum oil products hitting an 18-year low at 15.3 million tonnes in the fiscal year 2023-24, which ended on June 30, the government is estimated to have collected an outstanding Rs1 trillion in petroleum development levy (PDL) from the sale of oil products over the year. The collection of PDL at Rs60 per litre on the sale of petrol and diesel, coupled with the full pa

CPEC opens doors to tech-driven initiatives

Minister of State for IT and Telecommunication Shaza Fatima Khawaja on Tuesday said that the all-weather strategic cooperative partnership between Pakistan and China had opened doors to unparalleled opportunities in the information technology sector. “The China-Pakistan Economic Corridor (CPEC) serves as a cornerstone of bilateral cooperation between Pakistan and China, offering a multitude of

Pakistan, Azerbaijan to deepen economic ties

Deputy Foreign Minister of Azerbaijan, Samir Sharifov, met with Federal Minister for Commerce Jam Kamal Khan at his office, as stated in a press release on Tuesday. The meeting focused on strengthening economic and diplomatic relations between the two countries. Minister Jam Kamal Khan highlighted the Pakistani government’s dedication to forging robust economic relationships with other nations.

The budget and after

THE banker-turned-finance minister appeared nonplussed as he responded to the questions on Budget 2024-2025 that has burdened the already weighed-down salaried classes while protecting the privileged. He could only offer words of ‘sympathy and empathy’ to the affected people. His defence of exemptions extended to the top civil and military bureaucracy and retail businesses was equally superficial.

Citi Pharma partners with Indian firm

Citi Pharma, a Pakistani pharmaceutical company, has partnered with an Indian company, Murli Krishna Pharma Pvt Ltd (MKPL). Citi Pharma on Tuesday informed the shareholders in a stock filing that it has entered into an agreement with MKPL, a company incorporated and existing under the relevant laws of India. Under the agreement, MKPL will supply Citi Pharma Ltd. with Active Pharmaceutical In